GNA Biosolutions raises $13.5M for its first point-of-care molecular diagnostic

GNA Biosolutions raised $13.5 million to support its point-of-care molecular diagnostics platform designed to quickly examine samples taken from whole blood, sputum and nasal swabs.

Sourced through Scoop.it from: www.fiercebiotech.com